ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	54/594	191/7206	1.15433081095e-16
ko04380	Osteoclast differentiation	38/594	134/7206	4.21664562945e-12
ko05340	Primary immunodeficiency	16/594	30/7206	1.82391602314e-10
ko05164	Influenza A	40/594	167/7206	3.52061483438e-10
ko04650	Natural killer cell mediated cytotoxicity	29/594	97/7206	3.90523927909e-10
ko04621	NOD-like receptor signaling pathway	38/594	157/7206	7.14628640727e-10
ko05321	Inflammatory bowel disease (IBD)	21/594	56/7206	1.05231864767e-09
ko05140	Leishmaniasis	23/594	75/7206	1.53228964738e-08
ko04217	Necroptosis	38/594	178/7206	2.97846336e-08
ko04064	NF-kappa B signaling pathway	26/594	96/7206	3.16351986572e-08
ko05145	Toxoplasmosis	30/594	126/7206	6.87541196964e-08
ko04659	Th17 cell differentiation	27/594	106/7206	7.0277470652e-08
ko05330	Allograft rejection	12/594	24/7206	9.48243173348e-08
ko05162	Measles	28/594	120/7206	2.97011888502e-07
ko04620	Toll-like receptor signaling pathway	25/594	100/7206	3.18026523712e-07
ko04640	Hematopoietic cell lineage	19/594	64/7206	4.88519163312e-07
ko04660	T cell receptor signaling pathway	28/594	124/7206	6.10993882212e-07
ko04610	Complement and coagulation cascades	21/594	79/7206	9.47885078812e-07
ko05320	Autoimmune thyroid disease	12/594	29/7206	1.23718885271e-06
ko04658	Th1 and Th2 cell differentiation	23/594	96/7206	2.10324508408e-06
ko05150	Staphylococcus aureus infection	13/594	36/7206	2.78152224686e-06
ko05167	Kaposi's sarcoma-associated herpesvirus infection	36/594	191/7206	2.81487182621e-06
ko04672	Intestinal immune network for IgA production	13/594	37/7206	3.96904231065e-06
ko05332	Graft-versus-host disease	9/594	18/7206	4.08589983596e-06
ko05152	Tuberculosis	34/594	187/7206	9.20110455104e-06
ko04612	Antigen processing and presentation	19/594	77/7206	1.02472390432e-05
ko05168	Herpes simplex infection	33/594	182/7206	1.34072738405e-05
ko03013	RNA transport	1/594	166/7206	1.97070904224e-05
ko04062	Chemokine signaling pathway	35/594	201/7206	1.97405607498e-05
ko04662	B cell receptor signaling pathway	20/594	88/7206	2.24544237159e-05
ko05310	Asthma	8/594	17/7206	2.52998348072e-05
ko04668	TNF signaling pathway	24/594	120/7206	3.4338642663e-05
ko05133	Pertussis	19/594	87/7206	6.44071235579e-05
ko03040	Spliceosome	1/594	145/7206	9.10398365149e-05
ko00120	Primary bile acid biosynthesis	8/594	20/7206	0.000104871013762
ko05161	Hepatitis B	30/594	173/7206	0.000107340018892
ko04622	RIG-I-like receptor signaling pathway	15/594	62/7206	0.000111221766052
ko04390	Hippo signaling pathway	3/594	188/7206	0.000133288458496
ko05160	Hepatitis C	27/594	153/7206	0.000137686840849
ko00590	Arachidonic acid metabolism	13/594	52/7206	0.000222687162133
ko05323	Rheumatoid arthritis	18/594	89/7206	0.000279367588059
ko03010	Ribosome	1/594	129/7206	0.000290189036741
ko04137	Mitophagy - animal	17/594	82/7206	0.000301138693893
ko04630	Jak-STAT signaling pathway	23/594	132/7206	0.000568926895295
ko04940	Type I diabetes mellitus	9/594	32/7206	0.000824303093061
ko05144	Malaria	11/594	45/7206	0.000825363862709
ko05142	Chagas disease (American trypanosomiasis)	22/594	130/7206	0.0010211597458
ko04623	Cytosolic DNA-sensing pathway	10/594	41/7206	0.00143987100889
ko04670	Leukocyte transendothelial migration	24/594	151/7206	0.00149155303348
ko04145	Phagosome	25/594	162/7206	0.00206287200582
ko04611	Platelet activation	25/594	163/7206	0.0021726078433
ko04210	Apoptosis	27/594	180/7206	0.00219473854034
ko04666	Fc gamma R-mediated phagocytosis	20/594	122/7206	0.00246702773297
ko00592	alpha-Linolenic acid metabolism	6/594	19/7206	0.00326681384166
ko04068	FoxO signaling pathway	25/594	167/7206	0.00382960099158
ko04664	Fc epsilon RI signaling pathway	14/594	77/7206	0.00498658276016
ko03015	mRNA surveillance pathway	1/594	93/7206	0.00655695774151
ko04072	Phospholipase D signaling pathway	27/594	197/7206	0.00805965058425
ko04933	AGE-RAGE signaling pathway in diabetic complications	20/594	135/7206	0.0102492096058
ko05418	Fluid shear stress and atherosclerosis	24/594	173/7206	0.0109500877467
ko04310	Wnt signaling pathway	6/594	181/7206	0.0127950036297
ko04110	Cell cycle	4/594	145/7206	0.0133760760956
ko04514	Cell adhesion molecules (CAMs)	19/594	130/7206	0.0142704343803
ko04657	IL-17 signaling pathway	14/594	87/7206	0.0159270050308
ko05224	Breast cancer	6/594	174/7206	0.0168450814004
ko05134	Legionellosis	12/594	74/7206	0.018700609924
ko00051	Fructose and mannose metabolism	8/594	42/7206	0.0195742468868
ko05034	Alcoholism	10/594	238/7206	0.0218034743975
ko05131	Shigellosis	13/594	82/7206	0.0229559769557
ko05146	Amoebiasis	15/594	99/7206	0.0244748080596
ko00982	Drug metabolism - cytochrome P450	7/594	37/7206	0.0291836349475
ko01200	Carbon metabolism	4/594	128/7206	0.0332534675033
ko04070	Phosphatidylinositol signaling system	16/594	112/7206	0.0349688537727
ko05231	Choline metabolism in cancer	18/594	134/7206	0.0374389770935
ko05132	Salmonella infection	14/594	98/7206	0.039415870369
ko05230	Central carbon metabolism in cancer	12/594	81/7206	0.0401263240468
ko00980	Metabolism of xenobiotics by cytochrome P450	7/594	40/7206	0.042743017992
ko00950	Isoquinoline alkaloid biosynthesis	3/594	10/7206	0.0431492994609
ko00360	Phenylalanine metabolism	4/594	17/7206	0.0458435840114
ko00350	Tyrosine metabolism	6/594	33/7206	0.0499788136416